Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma
暂无分享，去创建一个
K. Shilo | R. Baiocchi | L. Alinari | P. Scherle | V. Valli | W. Kisseberth | H. Ozer | K. Vaddi | Xiaoli Zhang | Jihyun Chung | B. Klamer | A. S. Yilmaz | Y. Youssef | S. Schlotter | Mackenzie E Long | S. Sloan | Kyle A. Renaldo | Lindsay E. Courtney | F. Brown